Valdoxan, with the active ingredient agomelatine, is a novel antidepressant medication primarily used for the treatment of major depressive episodes in adults. Unlike traditional antidepressants, Valdoan operates through a dual mechanism of action: it acts as an agonist at melatonin receptors and as an antagonist at serotonin receptors. This unique approach not only helps in alleviating symptoms of depression by improving mood, sleep, and circadian rhythms but also tends to have fewer side effects compared to other antidepressants. Valdoxan's efficacy in improving overall depression symptoms, along with its positive impact on sleep patterns, makes it a distinctive option in the management of depression. However, it's important for patients to undergo regular liver function tests while on Valdoxan due to potential risks of liver toxicity.